Corporate Tech Investors

Cambrian Biopharma

Cambrian Biopharma is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Cambrian is a Distributed Drug Discovery Company, or a DisCo. We partner with leading academic institutions and biotech entrepreneurs to build start-up companies, providing capital and expertise to advance a pipeline of drug development programs with a shared theme. Each drug in our pipeline has the potential to extend healthy lifespan while treating and preventing multiple age-related diseases, including heart disease, cancer, dementia, metabolic disease, frailty, and many others that have become humanity's leading causes of death in the last century.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/17/2023

Transaction History

Our records indicate that Cambrian Biopharma invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

James Peyer

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Cambrian Biopharma has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Cambia Health Solutions | Cambridge Investment Research

Share this article

About Our Corporate Tech Investor Database

This corporate tech investment data comes via a partnership with VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary